Global Genetically Modified Drug Market Research Report 2023

Global Genetically Modified Drug Market Research Report 2023

Table of Contents
1 Genetically Modified Drug Market Overview
1.1 Product Overview and Scope of Genetically Modified Drug
1.2 Genetically Modified Drug Segment by Type
1.2.1 Global Genetically Modified Drug Market Value Comparison by Type (2023-2029)
1.2.2 Transgenic Animal
1.2.3 Transgenic Plant
1.3 Genetically Modified Drug Segment by Application
1.3.1 Global Genetically Modified Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Genetically Modified Drug Market Size Estimates and Forecasts
1.4.1 Global Genetically Modified Drug Revenue 2018-2029
1.4.2 Global Genetically Modified Drug Sales 2018-2029
1.4.3 Global Genetically Modified Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Genetically Modified Drug Market Competition by Manufacturers
2.1 Global Genetically Modified Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Genetically Modified Drug Average Price by Manufacturers (2018-2023)
2.4 Global Genetically Modified Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetically Modified Drug, Product Type & Application
2.7 Genetically Modified Drug Market Competitive Situation and Trends
2.7.1 Genetically Modified Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetically Modified Drug Players Market Share by Revenue
2.7.3 Global Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetically Modified Drug Retrospective Market Scenario by Region
3.1 Global Genetically Modified Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Genetically Modified Drug Global Genetically Modified Drug Sales by Region: 2018-2029
3.2.1 Global Genetically Modified Drug Sales by Region: 2018-2023
3.2.2 Global Genetically Modified Drug Sales by Region: 2024-2029
3.3 Global Genetically Modified Drug Global Genetically Modified Drug Revenue by Region: 2018-2029
3.3.1 Global Genetically Modified Drug Revenue by Region: 2018-2023
3.3.2 Global Genetically Modified Drug Revenue by Region: 2024-2029
3.4 North America Genetically Modified Drug Market Facts & Figures by Country
3.4.1 North America Genetically Modified Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Genetically Modified Drug Sales by Country (2018-2029)
3.4.3 North America Genetically Modified Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genetically Modified Drug Market Facts & Figures by Country
3.5.1 Europe Genetically Modified Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Genetically Modified Drug Sales by Country (2018-2029)
3.5.3 Europe Genetically Modified Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetically Modified Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Genetically Modified Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Genetically Modified Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Genetically Modified Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Genetically Modified Drug Market Facts & Figures by Country
3.7.1 Latin America Genetically Modified Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Genetically Modified Drug Sales by Country (2018-2029)
3.7.3 Latin America Genetically Modified Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetically Modified Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetically Modified Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Genetically Modified Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Genetically Modified Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genetically Modified Drug Sales by Type (2018-2029)
4.1.1 Global Genetically Modified Drug Sales by Type (2018-2023)
4.1.2 Global Genetically Modified Drug Sales by Type (2024-2029)
4.1.3 Global Genetically Modified Drug Sales Market Share by Type (2018-2029)
4.2 Global Genetically Modified Drug Revenue by Type (2018-2029)
4.2.1 Global Genetically Modified Drug Revenue by Type (2018-2023)
4.2.2 Global Genetically Modified Drug Revenue by Type (2024-2029)
4.2.3 Global Genetically Modified Drug Revenue Market Share by Type (2018-2029)
4.3 Global Genetically Modified Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Genetically Modified Drug Sales by Application (2018-2029)
5.1.1 Global Genetically Modified Drug Sales by Application (2018-2023)
5.1.2 Global Genetically Modified Drug Sales by Application (2024-2029)
5.1.3 Global Genetically Modified Drug Sales Market Share by Application (2018-2029)
5.2 Global Genetically Modified Drug Revenue by Application (2018-2029)
5.2.1 Global Genetically Modified Drug Revenue by Application (2018-2023)
5.2.2 Global Genetically Modified Drug Revenue by Application (2024-2029)
5.2.3 Global Genetically Modified Drug Revenue Market Share by Application (2018-2029)
5.3 Global Genetically Modified Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 LFB Biotechnologies SA
6.1.1 LFB Biotechnologies SA Corporation Information
6.1.2 LFB Biotechnologies SA Description and Business Overview
6.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 LFB Biotechnologies SA Genetically Modified Drug Product Portfolio
6.1.5 LFB Biotechnologies SA Recent Developments/Updates
6.2 Pharming Group NV
6.2.1 Pharming Group NV Corporation Information
6.2.2 Pharming Group NV Description and Business Overview
6.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pharming Group NV Genetically Modified Drug Product Portfolio
6.2.5 Pharming Group NV Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Genetically Modified Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roche Genetically Modified Drug Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Corporation Information
6.5.2 Abbott Laboratories Description and Business Overview
6.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abbott Laboratories Genetically Modified Drug Product Portfolio
6.5.5 Abbott Laboratories Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Genetically Modified Drug Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck & Co.
6.6.1 Merck & Co. Corporation Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck & Co. Genetically Modified Drug Product Portfolio
6.7.5 Merck & Co. Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Corporation Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Amgen Genetically Modified Drug Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 F. Hoffmann-La Roche
6.9.1 F. Hoffmann-La Roche Corporation Information
6.9.2 F. Hoffmann-La Roche Description and Business Overview
6.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio
6.9.5 F. Hoffmann-La Roche Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi Genetically Modified Drug Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Genetically Modified Drug Description and Business Overview
6.11.3 Novartis Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Genetically Modified Drug Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Eli Lilly
6.12.1 Eli Lilly Corporation Information
6.12.2 Eli Lilly Genetically Modified Drug Description and Business Overview
6.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Eli Lilly Genetically Modified Drug Product Portfolio
6.12.5 Eli Lilly Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Genetically Modified Drug Description and Business Overview
6.13.3 Takeda Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Takeda Genetically Modified Drug Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Baxter
6.14.1 Baxter Corporation Information
6.14.2 Baxter Genetically Modified Drug Description and Business Overview
6.14.3 Baxter Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Baxter Genetically Modified Drug Product Portfolio
6.14.5 Baxter Recent Developments/Updates
6.15 GlaxoSmithKline
6.15.1 GlaxoSmithKline Corporation Information
6.15.2 GlaxoSmithKline Genetically Modified Drug Description and Business Overview
6.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 GlaxoSmithKline Genetically Modified Drug Product Portfolio
6.15.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetically Modified Drug Industry Chain Analysis
7.2 Genetically Modified Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetically Modified Drug Production Mode & Process
7.4 Genetically Modified Drug Sales and Marketing
7.4.1 Genetically Modified Drug Sales Channels
7.4.2 Genetically Modified Drug Distributors
7.5 Genetically Modified Drug Customers
8 Genetically Modified Drug Market Dynamics
8.1 Genetically Modified Drug Industry Trends
8.2 Genetically Modified Drug Market Drivers
8.3 Genetically Modified Drug Market Challenges
8.4 Genetically Modified Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Genetically Modified Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Genetically Modified Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Genetically Modified Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Genetically Modified Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Genetically Modified Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Genetically Modified Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Genetically Modified Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Genetically Modified Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Genetically Modified Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Genetically Modified Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genetically Modified Drug, Product Type & Application
Table 12. Global Key Manufacturers of Genetically Modified Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genetically Modified Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genetically Modified Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Genetically Modified Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global Genetically Modified Drug Sales Market Share by Region (2018-2023)
Table 19. Global Genetically Modified Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Genetically Modified Drug Sales Market Share by Region (2024-2029)
Table 21. Global Genetically Modified Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Genetically Modified Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Genetically Modified Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Genetically Modified Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Genetically Modified Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Genetically Modified Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Genetically Modified Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Genetically Modified Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Genetically Modified Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Genetically Modified Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Genetically Modified Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Genetically Modified Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Genetically Modified Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Genetically Modified Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Genetically Modified Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Genetically Modified Drug Sales (K Units) by Type (2018-2023)
Table 51. Global Genetically Modified Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Genetically Modified Drug Sales Market Share by Type (2018-2023)
Table 53. Global Genetically Modified Drug Sales Market Share by Type (2024-2029)
Table 54. Global Genetically Modified Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Genetically Modified Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Genetically Modified Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Genetically Modified Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Genetically Modified Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Genetically Modified Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Genetically Modified Drug Sales (K Units) by Application (2018-2023)
Table 61. Global Genetically Modified Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Genetically Modified Drug Sales Market Share by Application (2018-2023)
Table 63. Global Genetically Modified Drug Sales Market Share by Application (2024-2029)
Table 64. Global Genetically Modified Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Genetically Modified Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Genetically Modified Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Genetically Modified Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Genetically Modified Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Genetically Modified Drug Price (US$/Unit) by Application (2024-2029)
Table 70. LFB Biotechnologies SA Corporation Information
Table 71. LFB Biotechnologies SA Description and Business Overview
Table 72. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. LFB Biotechnologies SA Genetically Modified Drug Product
Table 74. LFB Biotechnologies SA Recent Developments/Updates
Table 75. Pharming Group NV Corporation Information
Table 76. Pharming Group NV Description and Business Overview
Table 77. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pharming Group NV Genetically Modified Drug Product
Table 79. Pharming Group NV Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Genetically Modified Drug Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Genetically Modified Drug Product
Table 89. Roche Recent Developments/Updates
Table 90. Abbott Laboratories Corporation Information
Table 91. Abbott Laboratories Description and Business Overview
Table 92. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Abbott Laboratories Genetically Modified Drug Product
Table 94. Abbott Laboratories Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson Genetically Modified Drug Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Merck & Co. Corporation Information
Table 101. Merck & Co. Description and Business Overview
Table 102. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merck & Co. Genetically Modified Drug Product
Table 104. Merck & Co. Recent Developments/Updates
Table 105. Amgen Corporation Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Amgen Genetically Modified Drug Product
Table 109. Amgen Recent Developments/Updates
Table 110. F. Hoffmann-La Roche Corporation Information
Table 111. F. Hoffmann-La Roche Description and Business Overview
Table 112. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. F. Hoffmann-La Roche Genetically Modified Drug Product
Table 114. F. Hoffmann-La Roche Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi Genetically Modified Drug Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Novartis Genetically Modified Drug Product
Table 124. Novartis Recent Developments/Updates
Table 125. Eli Lilly Corporation Information
Table 126. Eli Lilly Description and Business Overview
Table 127. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Eli Lilly Genetically Modified Drug Product
Table 129. Eli Lilly Recent Developments/Updates
Table 130. Takeda Corporation Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Takeda Genetically Modified Drug Product
Table 134. Takeda Recent Developments/Updates
Table 135. Baxter Corporation Information
Table 136. Baxter Description and Business Overview
Table 137. Baxter Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Baxter Genetically Modified Drug Product
Table 139. Baxter Recent Developments/Updates
Table 140. GlaxoSmithKline Corporation Information
Table 141. GlaxoSmithKline Description and Business Overview
Table 142. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. GlaxoSmithKline Genetically Modified Drug Product
Table 144. GlaxoSmithKline Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Genetically Modified Drug Distributors List
Table 148. Genetically Modified Drug Customers List
Table 149. Genetically Modified Drug Market Trends
Table 150. Genetically Modified Drug Market Drivers
Table 151. Genetically Modified Drug Market Challenges
Table 152. Genetically Modified Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Genetically Modified Drug
Figure 2. Global Genetically Modified Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Genetically Modified Drug Market Share by Type in 2022 & 2029
Figure 4. Transgenic Animal Product Picture
Figure 5. Transgenic Plant Product Picture
Figure 6. Global Genetically Modified Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Genetically Modified Drug Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Genetically Modified Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Genetically Modified Drug Market Size (2018-2029) & (US$ Million)
Figure 12. Global Genetically Modified Drug Sales (2018-2029) & (K Units)
Figure 13. Global Genetically Modified Drug Average Price (US$/Unit) & (2018-2029)
Figure 14. Genetically Modified Drug Report Years Considered
Figure 15. Genetically Modified Drug Sales Share by Manufacturers in 2022
Figure 16. Global Genetically Modified Drug Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Genetically Modified Drug Players: Market Share by Revenue in 2022
Figure 18. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Genetically Modified Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Genetically Modified Drug Sales Market Share by Country (2018-2029)
Figure 21. North America Genetically Modified Drug Revenue Market Share by Country (2018-2029)
Figure 22. United States Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Genetically Modified Drug Sales Market Share by Country (2018-2029)
Figure 25. Europe Genetically Modified Drug Revenue Market Share by Country (2018-2029)
Figure 26. Germany Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Genetically Modified Drug Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Genetically Modified Drug Revenue Market Share by Region (2018-2029)
Figure 33. China Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Genetically Modified Drug Sales Market Share by Country (2018-2029)
Figure 41. Latin America Genetically Modified Drug Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Genetically Modified Drug Sales Market Share by Country (2018-2029)
Figure 46. Middle East & Africa Genetically Modified Drug Revenue Market Share by Country (2018-2029)
Figure 47. Turkey Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. UAE Genetically Modified Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Global Sales Market Share of Genetically Modified Drug by Type (2018-2029)
Figure 51. Global Revenue Market Share of Genetically Modified Drug by Type (2018-2029)
Figure 52. Global Genetically Modified Drug Price (US$/Unit) by Type (2018-2029)
Figure 53. Global Sales Market Share of Genetically Modified Drug by Application (2018-2029)
Figure 54. Global Revenue Market Share of Genetically Modified Drug by Application (2018-2029)
Figure 55. Global Genetically Modified Drug Price (US$/Unit) by Application (2018-2029)
Figure 56. Genetically Modified Drug Value Chain
Figure 57. Genetically Modified Drug Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs